苏州高泓利康生物科技有限公司

Suzhou Gmaxx Biologics Ltd. was founded in 2017. It is a leading technology enterprise in Suzhou Industrial Park. We are an innovation-driven biotech company dedicated to the development for new generation of therapeutics designed to meet the critical and pressing clinical needs of patients in China. The founder of Gmaxx, Dr. Guang Gao, has a master degree in pharmacology, a doctor degree in pathology in US and a postdoctoral experience in University of California at Berkeley. He returned to China from Stanford University in 2016, worked for a world-leading company and started his own business in 2017. Gmaxx is engaged in the research and development of new drugs in respiratory diseases, endocrine diseases and antiviral fields.